Crossmark

Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions

Crossref DOI link: https://doi.org/10.1007/s12471-019-1267-9

Published Online: 2019-04-04

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jacobs, M. S. http://orcid.org/0000-0002-6185-4718
van Hulst, M.

Campmans, Z.

Tieleman, R. G.
License Information

Text and Data Mining valid from 2019-04-04
More Information

Article History

First Online: 4 April 2019

Conflict of interest

: M.S. Jacobs and Z. Campmans declare that they have no conflict of interest. M. van Hulst reports grants from Bayer and personal fees from Boehringer Ingelheim all outside the submitted work. R.G. Tieleman reports grants and personal fees from Boehringer Ingelheim, personal fees from Bayer and personal fees from Pfizer/Bristol Meyer Squibb all outside the submitted work.